Purification of maturation-promoting factor, an intracellular regulator of early mitotic events by Lohka, Manfred J. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Papers in Veterinary and Biomedical Science Veterinary and Biomedical Sciences, Department of 
1988 
Purification of maturation-promoting factor, an intracellular 
regulator of early mitotic events 
Manfred J. Lohka 
Department of Pharmacology, University of Colorado School of Medicine, Denver, CO 80262 
Marianne K. Hayes 
University of Nebraska-Lincoln 
James L. Maller 
Department of Pharmacology, University of Colorado School of Medicine, Denver, CO 80262 
Follow this and additional works at: https://digitalcommons.unl.edu/vetscipapers 
 Part of the Veterinary Medicine Commons 
Lohka, Manfred J.; Hayes, Marianne K.; and Maller, James L., "Purification of maturation-promoting factor, 
an intracellular regulator of early mitotic events" (1988). Papers in Veterinary and Biomedical Science. 
120. 
https://digitalcommons.unl.edu/vetscipapers/120 
This Article is brought to you for free and open access by the Veterinary and Biomedical Sciences, Department of at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Papers in Veterinary and 
Biomedical Science by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Proc. Nat!. Acad. Sci. USA
Vol. 85, pp. 3009-3013, May 1988
Cell Biology
Purification of maturation-promoting factor, an intracellular
regulator of early mitotic events
(cell cycle/mitosis/protein phosphorylation)
MANFRED J. LOHKA*, MARIANNE K. HAYESt, AND JAMES L. MALLER
Department of Pharmacology, University of Colorado School of Medicine, Denver, CO 80262
Communicated by Raymond L. Erikson, December 22, 1987 (received for review October 10, 1987)
ABSTRACT Maturation-promoting factor causes germi-
nal vesicle breakdown when injected into Xenopus oocytes and
can induce metaphase in a cell-free system. The cell-free assay
was used to monitor maturation-promoting factor during its
purification from unfertilized Xenopus eggs. Ammonium sul-
fate precipitation and six chromatographic procedures resulted
in a preparation purified >3000-fold that could induce germi-
nal vesicle breakdown within 2 hr when injected into cyclo-
heximide-treated oocytes. Proteins of 45 kDa and 32 kDa were
correlated with fractions of highest activity in both assays.
These fractions contained a protein kinase activity able to
phosphorylate the endogenous 45-kDa protein, as well as
histone Hi, phosphatase inhibitor 1, and casein. The highly
purified preparations described here should help to identify the
mechanism of action of maturation-promoting factor and to
elucidate the role of protein kinases in the induction of
metaphase.
Two events mark the reproductive life of a eukaryotic cell;
replication of the genetic material in the S phase of the cell
cycle and segregation ofthe replicated DNA to daughter cells
during the mitotic phase (M phase). In most types of cells a
G1 phase separates the completion of M phase from the
beginning of S phase, whereas a G2 phase separates S phase
fromM phase. Two major control points in the cell cycle have
been identified (for review, see refs. 1 and 2). One such
control point is early in G1, and its regulation by serum and
peptide growth factors has been well documented (1, 3).
Another control point is late in G2. Certain cell division cycle
mutants in yeast and other fungi are defective in gene
products required for G2 -* M transition (4-6), and several
mammalian cell lines can be reversibly arrested in G2 by
N60t-dibutyryladenosine 3',5'-cyclic monophosphate (7,
8). Perhaps the best studied example of a cell naturally
arrested in G2 is the fully grown amphibian oocyte, which, in
response to hormones, enters M phase and matures into a
metaphase-arrested unfertilized egg (for review, see refs. 9
and 10). Upon fertilization, eggs complete meiosis II and
enter S phase. Thus, oocytes undergo a simple cell cycle
comprising a G2 -+M transition at maturation and then an
M - G1/S transition at fertilization.
When cytoplasm from maturing oocytes or eggs is injected
into immature oocytes, the recipients undergo oocyte matu-
ration, even in the absence of new protein synthesis (11, 12).
The active component in the transferred cytoplasm has been
called maturation-promoting factor (MPF). MPF has been
detected both in oocytes and in mitotic cells from many
species, ranging from yeast to man (10, 13). As MPF activity
oscillates with the cell cycle, becoming detectable in late G2
and disappearing in early G1, it may be a fundamental
regulator ofM phase in eukaryotes. Despite the importance
of MPF in the cell cycle, the protein(s) responsible for MPF
activity has not been identified as yet.
A cell-free system from amphibian eggs has been devel-
oped in which nuclei can be induced to undergo early mitotic
events by the addition of crude or partially purified prepa-
rations ofMPF (14-16). Experiments in this cell-free system
implicated protein phosphorylation in the mechanism of
action of MPF (17), results consistent with the observations
(18, 19) of increased protein phosphorylation when MPF
appears during oocyte maturation or after MPF injection. The
hypothesis that a protein kinase is involved in the regulation
of the G2 -* M transition is supported by observations of
increased phosphorylation of histones, lamins, and other
proteins during M phase (20, 21). Furthermore, in yeast at
least two of the mutations that cause arrest in G2 affect genes
encoding protein kinase activities (22-24). As genes encoding
proteins of similar sequence can also be detected in mam-
malian cells (25), protein kinases may have a widespread
importance in regulating the G2 -_+M transition. In fact, MPF
may be a phosphoprotein since its extraction from cells is
enhanced by the presence of phosphatase inhibitors (see ref.
13), and antibodies against thiophosphate immunoprecipitate
MPF from extracts prepared in the presence of adenosine
5'-['y-thio]triphosphate (ATP[ry-S]) (26).
In this paper, six chromatographic steps were used to
purify from Xenopus unfertilized eggs protein fractions that
are able to induce M phase in the cell-free assay and when
injected into immature, cycloheximide-treated Xenopus
oocytes. Fractions able to induce germinal vesicle break-
down (GVBD) in injected oocytes possessed a protein kinase
activity, although this kinase was either absent or greatly
reduced in some fractions that could induce M phase in the
cell-free system.
MATERIALS AND METHODS
Materials. Xenopus laevis were obtained from Xenopus I
(Ann Arbor, MI). ATP[y-S], a-naphthyl phosphate, and
4',6-diamidine-2-phenylindole were from Boehringer Mann-
heim, and Brij 35 was from Pierce. Bovine serum albumin
(BSA; Pentex, fraction V) was from Miles. All other reagents
were from Sigma. Green A Matrex gel was from Amicon.
DEAE-Sephacel, heparin-Sepharose, TSK 3000SW (0.8 cm
x 30 cm), Mono Q HR 5/5, and Mono S HR 5/5 columns
were from Pharmacia-LKB. [y-32P]ATP was prepared by the
procedure of Johnson and Walseth (27). The heat-stable
inhibitor of cAMP-dependent protein kinase (PKI) was pu-
Abbreviations: MPF, maturation-promoting factor; GVBD, germinal
vesicle breakdown; PKI, heat-stable inhibitor of cAMP-dependent
protein kinase; BSA, bovine serum albumin; ATP[y-S], adenosine
5'-[y-thio]triphosphate.
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rifled from rabbit skeletal muscle by the method of Walsh et
al. (28). NaDodSO4/PAGE was performed as described by
Laemmli (29).
Assay of MPF Activity in a Cell-Free System. Extracts able
to cause pronuclear formation in vitro were prepared as
described (15), and demembranated sperm nuclei were incu-
bated in these extracts for 1 hr. Then 25 ,l of the extract was
added to 50 Al of the sample to be assayed for MPF activity,
and the mixture was incubated for 2 hr at 19TC. Five to 10 ILI
of the mixture was removed after 1 or 2 hr, mixed with an
equal volume of a 4',6-diamidine-2-phenylindole solution (5
gg/ml), and observed by phase-contrast and fluorescence
microscopy.
A unit ofMPF activity was defined as the minimum amount
that causes at least 20% of the pronuclei to enter M phase
during a 2-hr incubation. To assess the amount of activity, a
sample was serially diluted 1:1 with 100 mM sodium f-
glycerophosphate/20 mM Hepes, pH 7.5/15 mM MgCl2/5
mM EGTA/1mM dithiothreitol. The reciprocal of the highest
dilution in which activity could be detected defined the
amount of activity initially present in 50 pl of the sample.
Assay of MPF Activity by Microinjection of Xenopus
Oocytes. After incubation for 30 min in OR-2 medium (37)
containing cycloheximide (0.5 Ag/ml) at a concentration that
inhibits both progesterone- and PKI-induced maturation,
groups of 5-10 oocytes (>1.2 mm in diameter) were micro-
injected with 100 nl of sample. Injected oocytes were incu-
bated for 2 hr at room temperature, and the fraction that
underwent GVBD was determined by scoring for "white
spot" formation. GVBD was confirmed by manually dissect-
ing oocytes after fixation in 10% (wt/vol) trichloroacetic acid.
Preparation of 250,000 x g Supernatants from Xenopus
Eggs. Sixty to 80 ml of dejellied eggs were washed with 400
ml of cold modified extraction buffer (MEB, ref. 19) consist-
ing of 80 mM sodium ,-glycerophosphate, 50 mM NaF, 20
mM EGTA, 15 mM MgCI2, 20 mM Hepes (pH 7.5), 1 mM
dithiothreitol, leupeptin (3 ,g/ml), and 300 ,uM phenyl-
methylsulfonyl fluoride. The MEB was decanted, and eggs
were suspended in 50 ml of MEB/20 mM a-naphthyl phos-
phate. The eggs were poured into 30-ml centrifuge tubes
containing 10-15 ml of MEB/20mM a-naphthyl phosphate.
After excess MEB was withdrawn, eggs were crushed by
centrifugation at 15,000 x g for 15 min. Crude cytoplasmic
fractions were pooled, and ATP[y-S] and cytochalasin B
were added to 1 mM and 10,g/ml, respectively. The crude
cytoplasmic fraction was again centrifuged for 15 min. The
material between the pellet and lipid cap was centrifuged for
4 hr at 50,000 rpm in a Beckman SW 55 rotor. Usually 60 ml
of dejellied eggs produced -30 ml of the crude cytoplasmic
fraction, from which -20 ml of particle-free supernatant was
obtained.
Purification ofMPF. A 0-34% (NH4)2SO4 fraction from the
supernatant was prepared by the addition of 0.6 vol of 3.8 M
(NH4)2SO4 dissolved in 80 mM sodium 8-glycerophos-
phate/15 mM MgCI2/20mM EGTA/20mM Hepes, pH 7.5/1
mM dithiothreitol. The mixture was incubated on ice for 30
min, and the precipitate was collected by centrifugation. The
precipitate was resuspended in 6 ml of dialysis buffer (DB;
100 mM sodium P3-glycerophosphate/15 mM MgCI2/5 mM
EGTA/20mM Hepes, pH 7.5/100,uM phenylmethylsulfonyl
fluoride/1 mM dithiothreitol), dialyzed against 80-100 vol of
DB for 4-6 hr, and stored at - 70°C.
The dialyzed (NH4)2SO4 fraction from 40 ml of particle-
free supernatant (15 ml) was thawed, diluted with 45 ml of
buffer A,(5mM MgCI2/2 mM EGTA/20mM Tris-HCI, pH
7.0/1mM dithiothreitol), and centrifuged for 15 min at 15,000
x g. The supernatant was applied to a DEAE-Sephacel
column (2.5 cm x 4.0 cm) that had been equilibrated with
buffer A/25 mM NaCl/1 mM 3-[(3-cholamidopropyl)di-
methylammonio]-1-propanesulfonate, and the column was
washed with buffer A/25 mM NaCl. Proteins were eluted
with buffer A/200 mM NaCl, and the eluate was applied
directly to a heparin-Sepharose column (2.5 cm x 4.0 cm)
equilibrated with buffer A/300 mM NaCl. The heparin-
Sepharose column was washed with buffer A/300 mM NaCl,
and proteins were eluted with buffer A/400 mM NaCl. The
eluate (=45 ml) was collected, diluted with 1/3 vol of buffer
A, and applied to a Green A Matrex gel column (1.1 cm x 4.0
cm) equilibrated with buffer A/300 mM NH4CI. Proteins
were eluted with buffer A/600 mM NH4CI and precipitated
by the addition of an equal volume of 3.8 M (NH4)2SO4
solution. The precipitate was resuspended in 200 ,1 of TSK
buffer (DB except phenylmethylsulfonyl fluoride was omit-
ted and 0.01% Brij 35 was added), loaded onto an LKB
Ultrochrom GTi HPLC, and subjected to gel filtration at a
flow rate of 0.05 ml/min through two TSK 3000SW columns
coupled in tandem. Fractions (0.5 ml) were collected and
assayed in the cell-free extracts. Active TSK fractions from
two purifications were pooled and diluted with 3 vol of buffer
A/0.01% Brij 35. The sample was applied to a Mono Q
column equilibrated with buffer B (buffer A/25 mM
NaCI/0.01% Brij 35), and the column was washed with buffer
B. Proteins were eluted with a 30-ml gradient to 275 mM NaCl
in buffer B. Fractions (1 ml) were collected, dialyzed over-
night against 1 liter of DB, and assayed in the cell-free
system. Fractions with activity were pooled and diluted with
3 vol of buffer C (buffer A except Tris HCI was replaced by
10 mM Hepes, pH 7.0/0.01% Brij 35). The sample was
applied to a Mono S column that had been equilibrated with
buffer C/25 mM NaCI, and the column was washed with
buffer C/25 mM NaCl. Proteins were eluted with a 30-ml
discontinuous gradient to 600 mM NaCl in buffer C. Frac-
tions (1 ml) were collected, dialyzed, and assayed.
Active Mono S fractions were divided into 50- or 100-pl
samples and stored at - 70°C. Preparations varied in their
stability after freezing and thawing, and in some cases 100
puM ATP (from a 1 mM stock at pH 7.0) was added to help
preserve MPF activity.
Determination of Protein Concentration. Protein concen-
tration was determined by the method of Bradford (30) for all
samples except the Mono S fractions. The amount of protein
in the Mono S fractions was determined by a modification of
the procedure of Graziani et al. (31). Samples (40, 20, and 10
plA) of each fraction were separated by NaDodSO4/PAGE on
10% polyacrylamide gels. Adjacent lanes contained 10-60 ng
of BSA. The gels were silver stained (32) and scanned by
using a Quick Scan R & D densitometer that was equipped
with an integrator pen and a pin-point slit (Helena Labora-
tories, Beaumont, TX). Two procedures were used to esti-
mate the total protein.
(i) The maximum absorbance was set to 60 ng of BSA, and
a standard curve was obtained. Under these conditions the
absorbance of 10, 15, and 20 ng of BSA was linear, and the
line extrapolated to zero. Mono S fractions were scanned,
and the amount of protein in each band was determined from
the linear portion of the standard curve. The total protein in
each fraction was calculated as the sum of the protein in each
band. By the use of this procedure the total protein in the
three active Mono S fractions in Table 1 was estimated to be
4.3,ug. However, with this maximal absorbance setting, the
sensitivity of the densitometer was too low to detect a few
minor proteins that could be detected visually. Therefore, an
alternative method was also used to estimate the amount of
protein.
(ii) The sensitivity of the densitometer was increased by
adjusting the absorbance so that 20 ng of BSA gave a maximal
value. However, at this sensitivity a linear standard curve
could not be obtained. Therefore, to provide an estimate of
the maximum amount of protein in a band, the absorbance of
the band in various dilutions of the sample was compared to
3010 Cell Biology: Lohka et al.
Proc. Natl. Acad. Sci. USA 85 (1988) 3011
that of 10 ng of BSA. Each band with an absorbance equal to
or less than that of 10 ng of BSA was designated to contain
10 ng ofprotein. By the use of this technique, the total protein
in the three active fractions in Table 1 was estimated to be 8.7
gg. The value obtained in this manner was an overestimate
ofthe actual amount of protein, since the absorbance ofmany
bands was less than one-half that of 10 ng of BSA. We have
used the mean of the values obtained by these two methods
as the total protein shown for Mono S fractions in Table 1.
Protein Kinase Assays. Phosphorylation of endogenous
substrates in the dialyzed Mono S fractions was performed by
mixing 45 A.l of sample with 5 1.l ofDB containing 1 mM ATP,
108 cpm of [y-32P]ATP, and 0.17 pug of PKI. Reactions were
incubated for 15 min at 30°C and terminated by the addition
of 1/4 vol of 5 x electrophoresis sample buffer (29). Proteins
were separated by NaDodSO4/PAGE on 10% gels, silver-
stained, and processed for autoradiography. Reactions with
histone H1 (type IIIS, 0.5 mg/ml) were carried out for 15 min
at 30°C in a final volume of 25 ,ul containing 2.5 ,ul of sample,
100 mM sodium P-glycerophosphate, 15 mM MgCl2, 5 mM
EGTA, 20 mM Hepes. (pH 7.5), 100 ,M ATP, 107 cpm of
[y-32P]ATP, 1 mM dithiothreitol, and 0.17 ,ug of PKI. The
reactions were terminated as described above, and proteins
were separated on 15% polyacrylamide gels.
RESULTS
Initial experiments involved efforts to optimize the extraction
and stabilization of MPF activity from eggs. Preliminary
experiments indicated that P-glycerophosphate, NaF, and
a-naphthyl phosphate, putative phosphatase inhibitors,
helped to increase recovery, and the addition of ATP[y-S]
was essential for stability during further purification. How-
ever, both a-naphthyl phosphate and NaF interfered with the
assay of MPF activity in the cell-free extracts and had to be
removed by dialysis prior to assay. In contrast, P3-glycero-
phosphate markedly increased the ability to detect MPF in
the assay, since activity often could not be detected without
prior dialysis against a j-glycerophosphate buffer. However,
f3-glycerophosphate alone was unable to induce M phase.
These results suggest that f3-glycerophosphate may have
additional properties besides phosphatase inhibition that help
to stabilize MPF activity. Even with the addition of ATP[y-S]
to extracts and the use of /3-glycerophosphate in the assay,
MPF activity was highly unstable.
MPF could be eluted from DEAE-Sephacel, heparin-
Sepharose, and Green A Matrex gel by sequential step
gradients. The 0-34% ammonium sulfate fraction was applied
to a DEAE-Sephacel column, and material was eluted with
200 mM NaCI. This step did not result in significant purifi-
cation but removed lipid and yolk components that interfered
with later steps. The eluate from DEAE-Sephacel was
Table 1. Summary of MPF purification from Xenopus eggs
applied directly to heparin-Sepharose, which was washed
with 300 mM NaCl, and material was eluted with 400 mM
NaCI. Although much protein was removed from the prep-
aration by this step, much activity was also lost, even though
none could be detected in the breakthrough fractions. Nev-
ertheless, the heparin-Sepharose step was necessary to
remove proteins that could not be removed by other columns
and to lower the total protein concentration to a level suitable
for later application onto the HPLC and FPLC columns. The
heparin-Sepharose eluate was applied to a Green A Matrex
gel column, and material was eluted with 600 mM NH4CI.
The sequential step gradients through DEAE-Sephacel, hep-
arin-Sepharose, and Green A Matrex gel removed >99% of
the protein from the starting material and resulted in an
=25-fold purification with a 10-15% yield (Table 1). The
pooled Green A Matrex gel eluate was precipitated with
ammonium sulfate, resuspended, and applied to a TSK
3000SW column. As shown in Fig. 1A, MPF activity eluted
as a broad peak with an apparent molecular mass of 200 kDa.
In some experiments active fractions were pooled and frozen
at - 70°C at this point, prior to combination with a TSK
eluate from another preparation. Active TSK fractions were
then chromatographed on a Mono Q column (Fig. 1B), where
MPF activity eluted at a NaCl concentration of 150 mM.
Active Mono Q fractions were pooled and applied to a Mono
S column, where MPF activity eluted at 250 mM NaCl (Fig.
1C). The final preparation was purified >3000-fold with a
recovery of 1% as shown in Table 1. In practice, the behavior
ofMPF on the TSK 3000SW and Mono Q columns was highly
reproducible, allowing us to pool fractions solely on the basis
of their position in the protein UV-absorbance profile,
without dialysis and assay. With this protocol only the Mono
S fractions were dialyzed and assayed, as were samples ofthe
eluates from all of the previous columns. The use of step
gradients and the ability to predict the behavior ofMPF on the
HPLC and FPLC columns enabled us to subject the 0-34%
ammonium sulfate sample to six chromatographic steps with
only a single assay within 54 hr. The speed of this procedure
may have helped to overcome the inherent instability ofMPF
during purification.
Fig. 2A shows a silver-stained polyacrylamide gel of the
fractions eluted from the Mono S column. Similar profiles
have been observed in six independent purifications. Several
proteins are visible in minor amounts in fractions with MPF
activity, but two proteins of 45 kDa and 32 kDa were
consistently observed in every preparation. These two pro-
teins fractionated with activity both when the Mono S column
followed the Mono Q column, as described above, and when
the order of these columns was reversed (data not shown).
The 45-kDa protein has a very close correlation with ability
to induce nuclear envelope breakdown and chromosome
condensation in the cell-free system, and the amount of this
Total Total Specific
protein, activity, activity, Recovery, Purification,
Step mg units x 10- units/mg S fold
Supernatant (250,000 x g) 2100 11.0 5.2 100
Ammonium sulfate 700 9.0 13 82 2.5
DEAE-Sephacel
Heparin-Sepharose 31 1.7 55 15 11
Green A Matrex gel 9.9 1.3 130 12 25
TSK 3000SW 1.7 0.48 280 4.4 54
Mono Q 0.07 0.20 2,900 1.8 560
Mono S* 0.0065 0.12 18,000 1.1 3500
Total protein of samples from the 250,000 x g supernatant through the TSK 3000SW step was the sum of that in two
separate preparations. After the TSK 3000SW step both preparations were applied to the Mono Q column. The
DEAE-Sephacel eluate was not analyzed as it was applied directly onto the heparin-Sepharose column.
*Only fractions 11-13 of Fig. 1C, which induced M phase in the cell-free system and GVBD in oocytes, are represented.
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FRACTION
A B
697 GOAi
43- *
_ia
30- ---a
NEBD (units) 0 0 1 1 2 2 1 1 0 0
GVBD (/) ) 0 0 0050 85 25 0 0 0
Fraction 6 9 12 15
Number
6 9 12 15
FIG. 2. Polyacrylamide gel analysis of fractions eluting from the
Mono S column. A 45-pl aliquot offractions 5-16 was incubated with
[y-*32P]ATP and electrophoresed through a 10%o NaDodSO4/poly-
E acrylamide gel. (A) Silver-stained polyacrylamide gel of purified
MPF. The activity of the fractions in the cell-free assay (NEBD) and
in the oocyte microinjection assay (GVBD) is shown below the gel.
NEBD is expressed in units/50 A.l. GVBD is expressed as the
percentage of oocytes that underwent GVBD during a 2-hr incuba-
tion in cycloheximide (0.5 Ag/ml). (B) Autoradiograph of the silver-
stained gel shown inA. (C) H1 kinase activity ofpurified MPF. Mono
S fractions 6-15 were assayed for H1 kinase activity. The autora-
diograph of the region of the gel with histone 1 is shown. Fraction 12
had a specific activity of -270 nmol min- '-mg- .
tion that incorporated radiolabel, and this occurred only in
fractions that were active in both assays. The same Mono S
fractions were able to phosphorylate histone H1 (Fig. 2C), as
well as phosphatase inhibitor 1, mixed histones, and casein
but not phosvitin, phosphatase inhibitor 2, glycogen syn-
E thase, ribosomal protein S6, lamins, or vimentin (data not
shown). Although the protein responsible for this kinase
activity has not been identified as yet, the 32-kDa protein
Z correlates with both protein kinase activity and induction of
GVBD. Side fractions that eluted earlier than the peak of
MPF possessed activity in the cell-free assay, but not in
oocytes, and showed little or no phosphorylation of the
45-kDa protein or other substrates.
FIG. 1. (A) Green A Matrex gel eluate was chromatographed on
a TSK 3000SW column. The cross-hatched area indicates the
fractions with activity. The positions of elution for ferritin (440 kDa;
VO), alcohol dehydrogenase (145 kDa), ovalbumin (43 kDa), and
cytochrome c (13 kDa) are indicated by arrows. (B) Chromatography
ofTSK 3000SW fractions on Mono Q. TSK 3000SW fractions 30-35
from two preparations were pooled and chromatographed on a Mono
Q. column. The cross-hatched area indicates the fractions with
activity. (C) Chromatography ofMono Q fractions on Mono S. Mono
Q fractions 10-14 were pooled and chromatographed on a Mono S
column. The cross-hatched region indicates fractions that had
activity in the cell-free assay. Fractions 11-13 induced GVBD when
injected into oocytes.
protein is greatest in fractions that induce GVBD in cyclo-
heximide-treated Xenopus oocytes. The 32-kDa protein also
correlated with fractions having the greatest MPF activity in
both assay systems but was absent from some side fractions
that had activity only in the cell-free assay (Fig. 2A).
In view of the evidence that protein phosphorylation is
involved in MPF action and the hypothesis that MPF may be
a protein kinase, fractions from the Mono S column were
examined for protein kinase activity. As shown in Fig. 2B, the
45-kDa protein was the only protein in the purified prepara-
DISCUSSION
The microinjection ofcytoplasm or its extracts into immature
oocytes ofechinoderms or amphibians has been the assay for
MPF activity for many years. In these systems MPF activity
is detected by its ability to induce the recipient to undergo
GVBD, which in cycloheximide-treated Xenopus oocytes
occurs within 2 hr. We and others have shown that partially
purified preparations of MPF can act in vitro to induce M
phase in nuclei incubated in extracts of Xenopus eggs
(14-16). In this paper, the response of interphase pronuclei in
the cell-free extracts was used to assay MPF during its
purification. The final purified preparations were able to
induce both M phase in cell-free extracts and GVBD in
injected Xenopus oocytes. Several purified proteins includ-
ing the regulatory subunit ofcAMP-dependent protein kinase
(9), PKI (9), and the human HRAS protein (33) have been
shown to induce GVBD when injected into oocytes. Al-
though these proteins can sometimes act almost as rapidly as
MPF, none is able to induce GVBD in cycloheximide-treated
oocytes. The preparations that we have obtained were able to
induce GVBD within 2 hr in cycloheximide-treated oocytes,
suggesting that genuine MPF activity has been purified.
0
00GoD4
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Studies have indicated (34) that surf clam egg cyclin A mRNA
can induce GVBD in Xenopus oocytes. However, cyclins
have not been identified as yet in Xenopus eggs, and the
relationship between cyclins and MPF is unknown.
In earlier work, partially purified preparations of MPF
from Xenopus eggs were shown by Coomassie blue staining
of NaDodSO4/polyacrylamide gels to have proteins of 62
kDa, 53 kDa, 49 kDa, 39 kDa, and 37 kDa (35). Preparations
from mitotic Hela cells were enriched in a 50-kDa protein
(36). In both cases only the final pooled fractions were
examined. We have used the more sensitive technique of
silver-staining NaDodSO4/polyacrylamide gels to visualize
proteins eluting from the Mono S column and have followed
the appearance and disappearance of proteins with changes
in MPF activity. In the preparations described here proteins
of 45 kDa and 32 kDa consistently fractionated with MPF
activity. The 45-kDa protein was invariably correlated with
the ability to induce M phase in the cell-free assay, and
proteins in neighboring fractions without the 32-kDa protein,
were also active in this assay. However, the presence of both
proteins was correlated with fractions able to induce GVBD
in oocytes. Since the 45-kDa protein was also more abundant
in these fractions, the ability of only the peak fractions to
induce GVBD may indicate that the cell-free assay is more
sensitive than the microinjection assay. The cell-free assay
may be able to detect lower levels of MPF activity because
samples that are tested make up 67% of the volume of the
reaction mixture, whereas they comprise only 5-10%o of the
oocyte volume after microinjection. However, the results are
also consistent with the possibility that the 45-kDa and
32-kDa proteins are required to induce GVBD, whereas the
45-kDa protein is sufficient to induce M phase in the cell-free
assay. (If the 32-kDa protein was already present in the egg
extracts, but not in immature oocytes, then the addition of the
45-kDa protein alone might be sufficient to induce M phase.)
Upon gel filtration through TSK 3000SW columns, MPF
eluted as a broad peak of =200 kDa. This behavior was
observed in seven consecutive experiments, and all data
presented in this paper were from such preparations. How-
ever, in other experiments MPF activity eluted with a lower
apparent molecular mass. Nevertheless, in such preparations
MPF behavior on Mono Q and Mono S remained the same as
shown in Fig. 1 B and C, and the 45-kDa and 32-kDa proteins
fractionated with MPF activity.
As described above, there is considerable evidence sug-
gesting that protein phosphorylation is involved in the mech-
anism of action of MPF. In this regard, it is of great interest
that protein kinase activity coeluted with MPF activity.
Phosphorylation of the 45-kDa protein was observed only
with fractions in which protein kinase activity against other
substrates was also detectable, suggesting that this protein
may be a substrate. It is not yet clear whether the protein
kinase activity or phosphorylation of the 45-kDa protein is
essential for MPF action. The first Mono S fractions with
activity in the cell-free assay elute ahead of the protein kinase
activity, suggesting that the protein kinase is not necessary
for the induction ofM phase in cell-free extracts. On the other
hand, fractions that are able to induce GVBD also have the
highest protein kinase activity. One might speculate that the
induction of GVBD requires the protein kinase activity in
addition to the 45-kDa protein. Since the 32-kDa protein
correlated with the protein kinase activity, it may be a second
component required to induce GVBD.
Regardless of whether the protein kinase that elutes with
MPF is necessary for GVBD, increases in protein phospho-
rylation inM phase are well documented. The nuclear lamins,
vimentin, and ribosomal protein S6, among others, are
known to be phosphorylated in maturing oocytes and mitotic
cells. As these proteins do not appear to be substrates for the
protein kinase in our preparation, MPF must be able to act
indirectly to control the phosphorylation of these substrates.
The purified preparations of MPF that we have described
may be useful in elucidating the mechanisms regulating the
transition from G2 to M phase in dividing cells and in defining
the role of protein phosphorylation in this transition.
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